Novelion Therapeutics Inc (NVLNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Operating Expenses | 7,769 | 6,643 | 7,503 | 7,125 | 7,219 |
| Operating Income | -7,769 | -6,643 | -7,503 | -7,125 | -7,219 |
| Other Income | 1,522 | 1,107 | 120 | 1,238 | 786 |
| Pre-tax Income | -6,247 | -5,536 | -7,383 | -5,887 | -6,433 |
| Income Tax | 215 | 165 | 109 | 142 | 183 |
| Net Income Continuous | -6,462 | -5,701 | -7,492 | -6,029 | -6,616 |
| Net Income Discontinuous | N/A | 852 | 96 | -170 | 189 |
| Net Income | $-6,462 | $-4,849 | $-7,396 | $-6,199 | $-6,427 |
| EPS Basic Total Ops | -0.65 | -0.50 | -0.70 | -0.60 | -0.65 |
| EPS Basic Continuous Ops | -0.65 | -0.55 | -0.75 | -0.60 | -0.65 |
| EPS Diluted Total Ops | -0.65 | -0.50 | -0.70 | -0.60 | -0.65 |
| EPS Diluted Continuous Ops | -0.65 | -0.55 | -0.75 | -0.60 | -0.65 |
| EBITDA(a) | $-7,540 | $-6,396 | $-7,273 | $-6,873 | $-6,984 |